These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 23475473)
1. The expression of estrogen receptors β2, 5 identifies and is associated with prognosis in non-small cell lung cancer. Liu Z; Liao Y; Tang H; Chen G Endocrine; 2013 Oct; 44(2):517-24. PubMed ID: 23475473 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Leung YK; Lam HM; Wu S; Song D; Levin L; Cheng L; Wu CL; Ho SM Endocr Relat Cancer; 2010 Sep; 17(3):675-89. PubMed ID: 20501637 [TBL] [Abstract][Full Text] [Related]
3. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041 [TBL] [Abstract][Full Text] [Related]
4. The co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in non-small-cell lung cancer progression. Liu ZG; Lei YY; Li WW; Chen ZG Med Oncol; 2013; 30(3):592. PubMed ID: 23677568 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis. Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer. Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma. Chantzi NI; Tiniakos DG; Palaiologou M; Goutas N; Filippidis T; Vassilaros SD; Dhimolea E; Mitsiou DJ; Alexis MN J Cancer Res Clin Oncol; 2013 Sep; 139(9):1489-98. PubMed ID: 23817696 [TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy. Schade GR; Holt SK; Zhang X; Song D; Wright JL; Zhao S; Kolb S; Lam HM; Levin L; Leung YK; Ho SM; Stanford JL J Urol; 2016 Jun; 195(6):1760-6. PubMed ID: 26804755 [TBL] [Abstract][Full Text] [Related]
9. Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers. Yan M; Rayoo M; Takano EA; ; Fox SB Breast Cancer Res Treat; 2011 Apr; 126(2):395-405. PubMed ID: 20490651 [TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression. Liu J; Sareddy GR; Zhou M; Viswanadhapalli S; Li X; Lai Z; Tekmal RR; Brenner A; Vadlamudi RK Cancer Res; 2018 Jun; 78(12):3176-3189. PubMed ID: 29661831 [TBL] [Abstract][Full Text] [Related]
11. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. Wong NA; Malcomson RD; Jodrell DI; Groome NP; Harrison DJ; Saunders PT J Pathol; 2005 Sep; 207(1):53-60. PubMed ID: 15954165 [TBL] [Abstract][Full Text] [Related]
12. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2. Fang F; Zheng Q; Zhang J; Dong B; Zhu S; Huang X; Wang Y; Zhao B; Li S; Xiong H; Chen J; Wu N; Song SW; Chang C; Yang Y Oncol Rep; 2013 Jan; 29(1):297-305. PubMed ID: 23129017 [TBL] [Abstract][Full Text] [Related]
13. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. Yan S; Dey P; Ziegler Y; Jiao X; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS Breast Cancer Res Treat; 2021 Jan; 185(2):281-292. PubMed ID: 33001337 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy. Dhimolea E; Tiniakos DG; Chantzi ΝΙ; Goutas N; Vassilaros SD; Mitsiou DJ; Alexis ΜN Cancer Lett; 2015 Mar; 358(1):37-42. PubMed ID: 25524554 [TBL] [Abstract][Full Text] [Related]
15. The potential role of estrogen receptor β2 in breast cancer. Baek JM; Chae BJ; Song BJ; Jung SS Int J Surg; 2015 Feb; 14():17-22. PubMed ID: 25450264 [TBL] [Abstract][Full Text] [Related]
16. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Mah V; Marquez D; Alavi M; Maresh EL; Zhang L; Yoon N; Horvath S; Bagryanova L; Fishbein MC; Chia D; Pietras R; Goodglick L Lung Cancer; 2011 Nov; 74(2):318-25. PubMed ID: 21511357 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor β and epidermal growth factor receptor as early-stage prognostic biomarkers of non-small cell lung cancer. Mauro LV; Dalurzo M; Carlini MJ; Smith D; Nuñez M; Simian M; Lastiri J; Vasallo B; Bal de Kier Joffé E; Pallotta MG; Puricelli L Oncol Rep; 2010 Nov; 24(5):1331-8. PubMed ID: 20878128 [TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological and prognostic significance of ERα and ERβ expression in lung carcinomas: a tissue microarray study]. Yang X; Xue LY; Liu Y; Guo L; Wen P; Lin DM Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):678-83. PubMed ID: 24332055 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells. Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. Dey P; Jonsson P; Hartman J; Williams C; Ström A; Gustafsson JÅ Mol Endocrinol; 2012 Dec; 26(12):1991-2003. PubMed ID: 23028063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]